Professor Jens K. Habermann, m.d., Ph.D.

President of ESBB (European, Middle Eastern and African Society for Biopreservation and Biobanking)

Professor Jens K. Habermann, m.d., Ph.D., is director of ICB-L (Interdisciplinary Center for Biobanking-Lübeck) and scientific director of UCCL (University Cancer Center Lübeck) at the University of Lübeck and University Clinic Schleswig-Holstein. He obtained his Ph.D. at the Karolinska Institutet (Stockholm, Sweden) and postdoc training at the NCI, NIH (Bethesda, USA). as specialist in human genetics, he combines clinical routine, biobanking, and cancer research to optimize individualized medicine by targeting tumor heterogeneity and applying liquid biopsies.

Prof. Habermann is president of ESBB (European, Middle Eastern & African society for Biopreservation & Biobanking) and board member of GBA (German Biobank Alliance).

Jens_Habermann_ESBB_BioTech_Pharma_Summit_2

Title: How clinical biobanks and strategic partnerships can support precision medicine: a Lübeck and ESBB perspective

  • Full integration of biobanking into the clinical context allow optimization of precision medicine and translational research
  • Major challenges remain in IT infrastructure, data protection and interconnectivity
  • Optimal utilization begins with sharing of resources, harmonization and standardization
  • National, international and global biobank networks offer new opportunities